Skip to main content
. 2022 Mar 16;9:850342. doi: 10.3389/fsurg.2022.850342

Table 5.

Recovery from disability trends using scaled erythrocytes and hemoglobin.

Predictors Baseline ODI 17-month ODI 17-month success %
RBCs (10 6 /μl)
<4 (n = 63) 55.48 ± 16.41 (24.00; 100.00) 32.54 ± 21.67 (00.00; 86.00) 58.73%
4–4.49 (n = 327) 48.45 ± 15.85 (14.00; 95.00) 25.47 ± 20.38 (00.00; 93.00) 70.64%
4.5–4.49 (n = 606) 46.04 ± 15.76 (13.00; 95.00) 21.83 ± 19.20 (00.00; 86.00) 73.93%
5–5.49 (n = 300) 45.68 ± 17.00 (13.00; 96.00) 19.52 ± 19.07 (00.00; 97.00) 77.33%
≥5.50 (n = 96) 44.33 ± 18.15 (14.00; 95.00) 18.95 ± 20.65 (00.00; 86.00) 77.08%
Hb (g/dl)
<12 (n = 87) 54.83 ± 14.82 (20.00; 84.00) 33.01 ± 23.78 (00.00; 86.00) 58.62%
12–12.9 (n = 195) 50.08 ± 16.57 (14.00; 100.00) 26.64 ± 19.92 (00.00; 93.00) 67.18%
13–13.9 (n = 373) 47.41 ± 15.22 (14.00; 95.00) 23.39 ± 19.00 (00.00; 80.00) 73.73%
14–14.9 (n = 380) 44.68 ± 15.69 (13.00; 91.00) 19.36 ± 18.88 (00.00; 97.00) 77.63%
15–15.9 (n = 237) 44.45 ± 16.83 (14.00; 88.00) 20.23 ± 19.31 (00.00; 90.00) 75.95%
≥16 (n = 120) 45.57 ± 19.38 (14.00; 96.00) 19.53 ± 20.29 (00.00; 78.00) 75.00%

ODI, Oswestry Disability Index, ranging from 0 (no disability) to 100 (maximum disability); RBCs, red blood cells; Hb, hemoglobin. Clinical success, a 30% decrease from preoperative ODI at 17 months after surgery.